Fatma M A Shoman

5‐(4‐Methoxybenzylidene)thiazolidine‐2,4‐dione‐derived VEGFR‐2 inhibitors: Design, synthesis, molecular docking, and anticancer evaluations

Khaled El-Adl, Helmy M. Sakr, Mohamed Alswah, 2020, Archiv der Pharmazie.